Why Edwards Lifesciences (EW) Stock Rose 5.75% in 10 Minutes After Q3 Earnings on Nov 4, 2026
Adjusted EPS of $0.80 came in above the $0.74 estimate; revenue of $1.72 billion came in above the $1.68 billion estimate.
- EW rose 5.75% in the 10 minutes after the 16:16:06 ET headline, from $98.35 to $104.00.
- The 5.75% gain was larger than any reaction MoveSurge measured after Edwards Lifesciences headlines between Aug 6, 2026 and Nov 3, 2026; the largest of those was -0.39% in 10 minutes, on Nov 2, 2026.
- 21,743 shares changed hands in those 10 minutes.
16:16:06 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| EW | 98.35 | 98.35 | 98.35 | 104.00 | 0.00% | +5.75% |
Edwards Lifesciences (EW) shares rose 5.75% in the 10 minutes after its Q3 results reached the MoveSurge news feed at 16:16:06 ET on Wednesday, November 4, 2026. Adjusted EPS of $0.80 came in above the $0.74 estimate; revenue of $1.72 billion came in above the $1.68 billion estimate.
EW in the first 10 minutes
The line that crossed at 16:16:06 ET: “EW (Edwards Lifesciences) Q3: adj. EPS 0.8 vs 0.74 est; revenue USD 1.72bln vs USD 1.68bln est”
From a reference price of $98.35 just before the headline, the stock was up 5.75%, at $104.00, after 10 minutes. 21,743 shares changed hands in those 10 minutes. The headline crossed in after-hours trading, 16 minutes after the 4:00 ET close.
Edwards Lifesciences Q3 results against estimates
| Measure | Reported | Estimate | Result |
|---|---|---|---|
| Adjusted EPS | $0.80 | $0.74 | Beat |
| Revenue | $1.72 billion | $1.68 billion | Beat |
Edwards Lifesciences FY26 guidance
| Measure | New range | Prior range | Estimate | Change |
|---|---|---|---|---|
| Adjusted EPS | $2.97 to $3.05 | $2.95 to $3.05 | $3.00 | Raised |
| Revenue | $6.77 billion | $6.6 billion to $6.9 billion | $6.77 billion | Narrowed |
| Adjusted EPS | $0.61 to $0.69 | — | $0.71 | — |
| Revenue | $1.67 billion to $1.75 billion | — | $1.7 billion | — |
How EW traded after earlier earnings releases
| Report | EPS vs estimate | Revenue vs estimate | First move |
|---|---|---|---|
| Jul 23, 2026 | $0.78 vs $0.74 | $1.74 billion vs $1.7 billion | +9.09% in 15 min |
Earlier EW headlines and the measured reaction
The 5.75% gain was larger than any reaction MoveSurge measured after Edwards Lifesciences headlines between Aug 6, 2026 and Nov 3, 2026; the largest of those was -0.39% in 10 minutes, on Nov 2, 2026.
- Nov 2, 2026, 12:51 ET: “Edwards Lifesciences (EW) faces selling pressure after an update on the TAVR trial progress.” (-0.39% in 10 minutes)
Edwards Lifesciences at a glance
| Sector | Health Care |
| Industry | Industrial Specialties |
| Market value | $54.87 billion (as of Nov 4, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
How did Edwards Lifesciences stock react to its Q3 earnings on November 4, 2026?
The stock rose 5.75% in the 10 minutes after its Q3 results crossed at 16:16:06 ET. Adjusted EPS of $0.80 came in above the $0.74 estimate; revenue of $1.72 billion came in above the $1.68 billion estimate.
How far did EW move after the headline?
From $98.35 just before the headline to $104.00 10 minutes later, a +5.75% move.
What did Edwards Lifesciences guide for adjusted EPS?
Adjusted EPS guidance of $2.97 to $3.05, replacing $2.95 to $3.05; the estimate was $3.00 (raised).
Sources
-
EW headline and measured reaction, Nov 4, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Go live — 7 days for $29 Watch live headlines -- free